Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales
Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales.
2 across the spectrum. Choose a side on the bar to jump to it.
National story. 2 articles from 2 sources. Updated 7d ago.
How each side is putting it
Left
1 sourceEli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales
Center
0 sourcesNo Center coverage yet.
A blind spot on this side of the story.
Right
1 sourceEli Lilly Blows Past Sales Expectations And Hikes Outlook On Mounjaro, Zepbound Dominance